PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.
PlusVitech has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
PlusVitech's investors include European Innovation Council, MassChallenge, Centre for the Development of Industrial Technology (CDTI).
PlusVitech is headquartered in Sevilla, Spain.
PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.
PlusVitech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PlusVitech — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/plusvitech. Accessed July 19, 2026.
VCBacked. (2025). PlusVitech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/plusvitech
{{cite web |title=PlusVitech — Funding & Investors |url=https://www.vcbacked.co/company/plusvitech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated